CABALETTA BIO, INCCABALETTA BIO, INCCABALETTA BIO, INC

CABALETTA BIO, INC

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−7.88MXN
Revenue estimate
Market capitalization
‪9.85 B‬MXN
−28.22MXN
‪−1.15 B‬MXN
‪37.98 M‬
Beta (1Y)
2.37

About Cabaletta Bio, Inc.

CEO
Steven Nichtberger
Headquarters
Philadelphia
Employees (FY)
103
Founded
2017
FIGI
BBG01JMJLHV6
Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CABA is 284.33 MXN — it has decreased by 22.45% in the past 24 hours. Watch CABALETTA BIO, INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange CABALETTA BIO, INC stocks are traded under the ticker CABA.
CABALETTA BIO, INC is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
CABA stock is 34.82% volatile and has beta coefficient of 2.37. Track CABALETTA BIO, INC stock price on the chart and check out the list of the most volatile stocks — is CABALETTA BIO, INC there?
CABA earnings for the last quarter are −6.45 MXN per share, whereas the estimation was −7.03 MXN resulting in a 8.29% surprise. The estimated earnings for the next quarter are −6.67 MXN per share. See more details about CABALETTA BIO, INC earnings.
Yes, you can track CABALETTA BIO, INC financials in yearly and quarterly reports right on TradingView.
CABA stock has risen by 4.56% compared to the previous week, the month change is a 23.79% fall, over the last year CABALETTA BIO, INC has showed a 18.83% decrease.
CABA net income for the last quarter is ‪−354.75 M‬ MXN, while the quarter before that showed ‪−286.70 M‬ MXN of net income which accounts for −23.74% change. Track more CABALETTA BIO, INC financial stats to get the full picture.
Today CABALETTA BIO, INC has the market capitalization of ‪9.85 B‬, it has decreased by 2.70% over the last week.
No, CABA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CABA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CABALETTA BIO, INC stock right from TradingView charts — choose your broker and connect to your account.
As of May 5, 2024, the company has 103.00 employees. See our rating of the largest employees — is CABALETTA BIO, INC on this list?
We've gathered analysts' opinions on CABALETTA BIO, INC future price: according to them, CABA price has a max estimate of 827.87 MXN and a min estimate of 413.93 MXN. Watch CABA chart and read a more detailed CABALETTA BIO, INC stock forecast: see what analysts think of CABALETTA BIO, INC and suggest that you do with its stocks.